Edition:
India

Anthem Inc (ANTM.N)

ANTM.N on New York Stock Exchange

269.00USD
6 Jul 2020
Change (% chg)

$2.00 (+0.75%)
Prev Close
$267.00
Open
$271.37
Day's High
$271.37
Day's Low
$267.13
Volume
226,145
Avg. Vol
454,676
52-wk High
$312.44
52-wk Low
$171.33

Latest Key Developments (Source: Significant Developments)

Anthem Intend To Reaffirm 2020 EPS Outlook To Be More Than $21.00
Tuesday, 9 Jun 2020 

June 9 (Reuters) - Anthem Inc ::INTEND TO REAFFIRM EARNINGS PER SHARE GUIDANCE FOR FY 2020 TO BE GREATER THAN $21.00, INCLUDING ABOUT $1.30 PER SHARE OF NET UNFAVORABLE ITEMS.EXCLUDING ITEMS, CONTINUES TO EXPECT ADJUSTED EARNINGS PER SHARE TO BE GREATER THAN $22.30 FOR FY 2020.NOW EXPECTS TO GENERATE ABOUT 70% OF ITS ADJUSTED EPS IN H1 2020.FY2020 EARNINGS PER SHARE VIEW $22.22 -- REFINITIV IBES DATA.  Full Article

Anthem Says COVID-19 Crisis Could Drive Shift In Consumers From Employer Market To Medicaid, ACA Segments - Conf Call
Wednesday, 29 Apr 2020 

April 29 (Reuters) - Anthem Inc ::ANTHEM INC SAYS THE COVID-19 CRISIS COULD DRIVE AN UNPRECEDENTED SHIFT IN CONSUMERS FROM THE EMPLOYER MARKET INTO ITS MEDICAID AND ACA SEGMENTS - CONF CALL.ANTHEM INC SAYS SECOND QUARTER BENEFIT EXPENSE RATIO IS EXPECTED TO BE WELL BELOW HISTORIC LEVELS - CONF CALL.ANTHEM SAYS BENEFIT EXPENSE RATIO IS EXPECTED TO BE ELEVATED IN 2H 2020 AS ELECTIVE PROCEDURES RETURN - CONF CALL.ANTHEM SAYS CONFIDENT AROUND ENDING THE YEAR AT THE MIDPOINT OF TARGET MARGIN RANGE OF 2% TO 4% FOR MEDICAID - CONF CALL.ANTHEM SAYS INVESTMENT INCOME AND INTEREST EXPENSE TO BE A HEADWIND FOR THE REST OF 2020 - CONF CALL.ANTHEM SAYS ABOUT 30% TO 40% OF ITS "ANNUAL MEDICAL EXPENSE" IS ESTIMATED TO BE RELATED TO DEFERRABLE ELECTIVE PROCEDURES - CONF CALL.  Full Article

Anthem Posts Q1 Adjusted Earnings Per Share Of $6.48
Wednesday, 29 Apr 2020 

April 29 (Reuters) - Anthem Inc ::Q1 ADJUSTED EARNINGS PER SHARE $6.48.Q1 GAAP EARNINGS PER SHARE $5.94 INCLUDING ITEMS.Q1 REVENUE $29.4 BILLION VERSUS REFINITIV IBES ESTIMATE OF $28.6 BILLION.Q1 EARNINGS PER SHARE ESTIMATE $6.48 -- REFINITIV IBES DATA.BENEFIT EXPENSE RATIO WAS 84.2 PERCENT IN Q1 OF 2020, A DECREASE OF 20 BASIS POINTS FROM 84.4 PERCENT IN PRIOR YEAR QUARTER.QTRLY MEDICAL ENROLLMENT TOTALED 42.1 MILLION MEMBERS AT MARCH 31, 2020, AN INCREASE OF 1.3 MILLION MEMBERS.FY 2020 GAAP NET INCOME EXPECTED TO BE GREATER THAN $21.00 PER SHARE, INCLUDING APPROXIMATELY $1.30 PER SHARE OF NET UNFAVORABLE ITEMS.COMPANY IS WITHDRAWING ALL OTHER PREVIOUSLY ISSUED FINANCIAL GUIDANCE METRICS FOR 2020 UNTIL VISIBILITY IMPROVES DUE TO COVID-19.FULL YEAR 2020 ADJUSTED NET INCOME IS EXPECTED TO BE GREATER THAN $22.30 PER SHARE.Q1 EARNINGS PER SHARE VIEW $6.48 -- REFINITIV IBES DATA.Q1 REVENUE VIEW $28.60 BILLION -- REFINITIV IBES DATA.FY2020 EARNINGS PER SHARE VIEW $22.02 -- REFINITIV IBES DATA.  Full Article

Anthem Offers Up To 80 Hours Of Paid Emergency Leave For Qualifying Needs
Friday, 20 Mar 2020 

March 19 (Reuters) - Anthem Inc ::ANTHEM -OFFERING UP TO 80 HOURS OF PAID EMERGENCY LEAVE FOR QUALIFYING NEEDS - INCLUDING IF ASSOCIATES ARE EXPERIENCING SYMPTOMS OF COVID-19.  Full Article

Anthem Continues To Expect Adjusted Net Income To Be Greater Than $22.30 Per Share In 2020
Tuesday, 10 Mar 2020 

March 9 (Reuters) - Anthem Inc ::TO REAFFIRM COMPANY'S NET INCOME GUIDANCE FOR FULL YEAR 2020 TO BE GREATER THAN $21.44 PER SHARE.EXCLUDING ITEMS, COMPANY CONTINUES TO EXPECT ADJUSTED NET INCOME TO BE GREATER THAN $22.30 PER SHARE IN 2020.FY2020 EARNINGS PER SHARE VIEW $22.45 -- REFINITIV IBES DATA.  Full Article

Anthem Reports Reports Q4 Earnings Per Share Of $3.62
Wednesday, 29 Jan 2020 

Jan 29 (Reuters) - Anthem Inc ::ANTHEM REPORTS FOURTH QUARTER AND FULL YEAR 2019 RESULTS REFLECTING SOLID PERFORMANCE.Q4 EARNINGS PER SHARE $3.62.Q4 REVENUE $27.1 BILLION VERSUS REFINITIV IBES ESTIMATE OF $27.1 BILLION.Q4 EARNINGS PER SHARE ESTIMATE $3.88 -- REFINITIV IBES DATA.Q4 ADJUSTED EARNINGS PER SHARE $3.88.MEDICAL ENROLLMENT TOTALED 41.0 MILLION MEMBERS AT DECEMBER 31, 2019, AN INCREASE OF 1.1 MILLION, OR 2.7 PERCENT, FROM DECEMBER 31, 2018.BENEFIT EXPENSE RATIO WAS 89.0 PERCENT IN Q4 OF 2019, AN INCREASE OF 220 BASIS POINTS FROM 86.8 PERCENT IN PRIOR YEAR QUARTER.FOR FULL YEAR 2019, LOCAL GROUP MEDICAL COST TREND WAS APPROXIMATELY 6.0%.SEES FY 2020 MEDICAL MEMBERSHIP IS EXPECTED TO BE IN RANGE OF 41.9 - 42.3 MILLION.SEES FY 2020 FULLY-INSURED MEMBERSHIP IS EXPECTED TO BE IN RANGE OF 16.0 - 16.3 MILLION.ANTHEM - EXCPECTS LOCAL GROUP MEDICAL COST TREND WILL BE IN RANGE OF 4.0% +/- 50 BASIS POINTS IN 2020, INCLUDING BENEFIT OF IMPROVED PHARMACY COST.SEES FY 2020 BENEFIT EXPENSE RATIO IS EXPECTED TO BE IN RANGE OF 85.8% PLUS OR MINUS 50 BASIS POINTS.SEES FY 2020 OPERATING REVENUE IS EXPECTED TO BE APPROXIMATELY $117 BILLION, INCLUDING PREMIUM REVENUE OF $101 BILLION - $103 BILLION.  Full Article

Anthem CEO Says "Very Positive" About Overall Medicaid Environment Going Forward
Wednesday, 23 Oct 2019 

Oct 23 (Reuters) - Anthem Inc ::ANTHEM SAYS ON TRACK TO HAVE ALL MEMBERS MIGRATE TO INGENIORX PLATFORM BY JAN 1, 2020 - CONF. CALL.ANTHEM SAYS UNFAVORABLE TRENDS IN MEDICAL COSTS ISOLATED TO COMMERCIAL SEGMENT - CONF. CALL.ANTHEM CEO SAYS CHALLENGES CO FACES HEADING INTO 2020 ARE "MANAGEABLE" - CONF. CALL.ANTHEM CEO SEES 2020 CORE EPS GROWTH AT LOW END OF 12% TO 15% TARGET GROWTH RATE RELATIVE TO ORIGINAL 2019 GUIDANCE - CONF. CALL.ANTHEM CEO SAYS CONTINUES TO EXPECT NEW PBM INGENIORX WILL PRODUCE TOTAL OPERATING GAIN OF AT LEAST $800 MILLION OR ROUGHLY $2.30 PER SHARE IN 2020 - CONF. CALL.ANTHEM SAYS INCREASE IN 2019 CONSOLIDATED MEDICAL LOSS RATIO IS DUE TO MEDICAID- CONF. CALL.ANTHEM SAYS "VERY BULLISH" FOR 2020 SELLING SEASON FOR MEDICARE - CONF. CALL.ANTHEM CEO SAYS "VERY POSITIVE" ABOUT THE OVERALL MEDICAID ENVIRONMENT BUSINESS GOING FORWARD - CONF. CALL.  Full Article

Anthem Reports Third Quarter 2019 Results
Wednesday, 23 Oct 2019 

Oct 23 (Reuters) - Anthem Inc ::ANTHEM REPORTS THIRD QUARTER 2019 RESULTS.Q3 EARNINGS PER SHARE $4.55.Q3 REVENUE $26.4 BILLION VERSUS REFINITIV IBES ESTIMATE OF $25.9 BILLION.Q3 ADJUSTED EARNINGS PER SHARE $4.87.Q3 EARNINGS PER SHARE ESTIMATE $4.82 -- REFINITIV IBES DATA.FULL YEAR ADJUSTED NET INCOME IS NOW EXPECTED TO BE GREATER THAN $19.40* PER SHARE..COMPANY NOW EXPECTS FULL YEAR NET INCOME TO BE GREATER THAN $18.45 PER SHARE..Q4 2019 DIVIDEND OF $0.80 PER SHARE DECLARED TO SHAREHOLDERS.MEDICAL ENROLLMENT TOTALED APPROXIMATELY 41.0 MILLION MEMBERS AT SEPT 30, 2019, AN INCREASE OF 1.1 MILLION, OR 2.7 PERCENT, FROM SEPT 30, 2018.BENEFIT EXPENSE RATIO WAS 87.2 PERCENT IN Q3 OF 2019, AN INCREASE OF 240 BASIS POINTS FROM 84.8 PERCENT IN PRIOR YEAR QUARTER.FY 2019 OPERATING REVENUE IS NOW EXPECTED TO BE APPROXIMATELY $103.0 BILLION, INCLUDING PREMIUM REVENUE OF $94.0 BILLION TO $95.0 BILLION.FOR FULL YEAR 2019, CO CONTINUES TO EXPECT UNDERLYING LOCAL GROUP MEDICAL COST TREND WILL BE IN RANGE OF 6.0% PLUS/MINUS 50 BASIS POINTS.FY 2019 BENEFIT EXPENSE RATIO IS NOW EXPECTED TO BE IN RANGE OF 86.5% TO 86.8%.FY2019 EARNINGS PER SHARE VIEW $19.35, REVENUE VIEW $101.87 BILLION -- REFINITIV IBES DATA.  Full Article

Centene And Wellcare Announce Agreement Between Wellcare And Anthem To Divest Missouri And Nebraska Medicaid Plans
Thursday, 26 Sep 2019 

Sept 26 (Reuters) - Centene Corp ::PRESS RELEASE - CENTENE AND WELLCARE ANNOUNCE AGREEMENT BETWEEN WELLCARE AND ANTHEM, INC., TO DIVEST MISSOURI AND NEBRASKA MEDICAID PLANS.CENTENE AND WELLCARE ANNOUNCE AGREEMENT BETWEEN WELLCARE AND ANTHEM, INC., TO DIVEST MISSOURI AND NEBRASKA MEDICAID PLANS.CENTENE CORP - ANNOUNCES ADDITIONAL STATE APPROVALS WITH CALIFORNIA AND WISCONSIN.CENTENE CORP - WELLCARE TRANSACTION WILL BE COMPLETED BY FIRST HALF OF 2020..  Full Article

Anthem Inc Prices Three-Part Notes Offering Of Up To $2.5 Bln
Friday, 6 Sep 2019 

Sept 6 (Reuters) - Anthem Inc ::ANTHEM INC PRICES THREE-PART NOTES OFFERING OF UP TO $2.5 BILLION - SEC FILING.ANTHEM INC SAYS PRICES $850 MILLION 2.375% NOTES DUE 2025, $825 MILLION 2.875% NOTES DUE 2029 AND $825 MILLION 3.700% NOTES DUE 2049 - SEC FILING.  Full Article

BRIEF-Anthem Intend To Reaffirm 2020 EPS Outlook To Be More Than $21.00

* INTEND TO REAFFIRM EARNINGS PER SHARE GUIDANCE FOR FY 2020 TO BE GREATER THAN $21.00, INCLUDING ABOUT $1.30 PER SHARE OF NET UNFAVORABLE ITEMS